Literature DB >> 18091563

Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis.

Sanna Partanen1, Aleksi Haapanen, Catherine Kielar, Charles Pontikis, Noreen Alexander, Teija Inkinen, Paul Saftig, Thomas H Gillingwater, Jonathan D Cooper, Jaana Tyynelä.   

Abstract

Cathepsin D (CTSD; EC 3.4.23.5) is a lysosomal aspartic protease, the deficiency of which causes early-onset and particularly aggressive forms of neuronal ceroid-lipofuscinosis in infants, sheep, and mice. Cathepsin D deficiencies are characterized by severe neurodegeneration, but the molecular mechanisms behind the neuronal death remain poorly understood. In this study, we have systematically mapped the distribution of neuropathologic changes in CTSD-deficient mouse brains by stereologic, immunologic, and electron microscopic methods. We report highly accentuated neuropathologic changes within the ventral posterior nucleus (ventral posteromedial [VPM]/ventral posterolateral [VPL]) of thalamus and in neuronal laminae IV and VI of the somatosensory cortex (S1BF), which receive and send information to the thalamic VPM/VPL. These changes included pronounced astrocytosis and microglial activation that begin in the VPM/VPL thalamic nucleus of CTSD-deficient mice and are associated with reduced neuronal number and redistribution of presynaptic markers. In addition, loss of synapses, axonal pathology, and aggregation of synaptophysin and synaptobrevin were observed in the VPM/VPL. These synaptic alterations are accompanied by changes in the amount of synaptophysin/synaptobrevin heterodimer, which regulates formation of the SNARE complex at the synapse. Taken together, these data reveal the somatosensory thalamocortical circuitry as a particular focus of pathologic changes and provide the first evidence for synaptic alterations at the molecular and ultrastructural levels in CTSD deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18091563     DOI: 10.1097/nen.0b013e31815f3899

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  36 in total

1.  [NCL in animal models].

Authors:  K Rüther
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

2.  Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).

Authors:  Graham W Kay; Marcel M Verbeek; Julie M Furlong; Michèl A A P Willemsen; David N Palmer
Journal:  Neurochem Int       Date:  2009-08-05       Impact factor: 3.921

3.  Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities.

Authors:  Jakub Sikora; Shaalee Dworski; E Ellen Jones; Mustafa A Kamani; Matthew C Micsenyi; Tomo Sawada; Pauline Le Faouder; Justine Bertrand-Michel; Aude Dupuy; Christopher K Dunn; Ingrid Cong Yang Xuan; Josefina Casas; Gemma Fabrias; David R Hampson; Thierry Levade; Richard R Drake; Jeffrey A Medin; Steven U Walkley
Journal:  Am J Pathol       Date:  2017-04       Impact factor: 4.307

4.  α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2.

Authors:  Lauren R Kett; Barbara Stiller; Megan M Bernath; Inmaculada Tasset; Javier Blesa; Vernice Jackson-Lewis; Robin B Chan; Bowen Zhou; Gilbert Di Paolo; Serge Przedborski; Ana Maria Cuervo; William T Dauer
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

5.  Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis.

Authors:  André R A Marques; Alessandro Di Spiezio; Niklas Thießen; Lina Schmidt; Joachim Grötzinger; Renate Lüllmann-Rauch; Markus Damme; Steffen E Storck; Claus U Pietrzik; Jens Fogh; Julia Bär; Marina Mikhaylova; Markus Glatzel; Mahmoud Bassal; Udo Bartsch; Paul Saftig
Journal:  Autophagy       Date:  2019-07-16       Impact factor: 16.016

6.  Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL.

Authors:  Carina von Schantz; Catherine Kielar; Stine N Hansen; Charlie C Pontikis; Noreen A Alexander; Outi Kopra; Anu Jalanko; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2009-05       Impact factor: 5.996

Review 7.  Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges.

Authors:  Lauren R Kett; William T Dauer
Journal:  Mov Disord       Date:  2016-10       Impact factor: 10.338

8.  Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.

Authors:  Catherine Kielar; Thomas M Wishart; Alice Palmer; Sybille Dihanich; Andrew M Wong; Shannon L Macauley; Chun-Hung Chan; Mark S Sands; David A Pearce; Jonathan D Cooper; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2009-07-29       Impact factor: 6.150

9.  Expression of the neuroprotective slow Wallerian degeneration (WldS) gene in non-neuronal tissues.

Authors:  Thomas M Wishart; David G Brownstein; Derek Thomson; Anca M Tabakova; Katherine M Boothe; Jack W Tsao; Thomas H Gillingwater
Journal:  BMC Neurosci       Date:  2009-12-16       Impact factor: 3.288

10.  Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.

Authors:  Valerie Cullen; Maria Lindfors; Juliana Ng; Anders Paetau; Erika Swinton; Piotr Kolodziej; Heather Boston; Paul Saftig; John Woulfe; Mel B Feany; Liisa Myllykangas; Michael G Schlossmacher; Jaana Tyynelä
Journal:  Mol Brain       Date:  2009-02-09       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.